Variant report
Variant | esv17385 |
---|---|
Chromosome Location | chr17:20446442-20460042 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:24)
- CpG islands (count:550)
- Chromatin interactive region (count:0)
- LncRNA region (count:5)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:24 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr17:20449270-20449503 | GM12878 | blood: | n/a | n/a |
2 | CTCF | chr17:20458700-20458826 | Spleen_OC | spleen: | n/a | n/a |
3 | CTCF | chr17:20458747-20458804 | GM12892 | blood: | n/a | n/a |
4 | CTCF | chr17:20448391-20448410 | Kidney_OC | kidney: | n/a | n/a |
5 | CTCF | chr17:20456367-20456424 | GM19240 | blood: | n/a | n/a |
6 | CTCF | chr17:20452453-20452487 | LNCaP | prostate: | n/a | n/a |
7 | CTCF | chr17:20457903-20457938 | Lung_OC | lung: | n/a | n/a |
8 | CTCF | chr17:20458722-20458873 | GM12891 | blood: | n/a | n/a |
9 | FOSL2 | chr17:20453744-20454093 | HepG2 | liver: | n/a | n/a |
10 | FOSL2 | chr17:20452869-20453245 | HepG2 | liver: | n/a | n/a |
11 | FOSL2 | chr17:20448386-20448629 | HepG2 | liver: | n/a | n/a |
12 | GABPA | chr17:20450160-20450376 | Hela-S3 | cervix: | n/a | n/a |
13 | GABPA | chr17:20455798-20455929 | Hela-S3 | cervix: | n/a | n/a |
14 | PAX5 | chr17:20451052-20451297 | GM12878 | blood: | n/a | n/a |
15 | POLR2A | chr17:20458934-20459000 | GM12878 | blood: | n/a | n/a |
16 | POLR2A | chr17:20456076-20456237 | GM12878 | blood: | n/a | n/a |
17 | REST | chr17:20453422-20453685 | H1-hESC | embryonic stem cell: | n/a | chr17:20453568-20453577 |
18 | REST | chr17:20458578-20458784 | PANC-1 | pancreas: | n/a | chr17:20458681-20458691 |
19 | SPI1 | chr17:20458700-20458928 | GM12878 | blood: | n/a | chr17:20458823-20458832 |
20 | SPI1 | chr17:20458692-20459021 | GM12891 | blood: | n/a | chr17:20458823-20458832 |
21 | SPI1 | chr17:20447005-20447192 | K562 | blood: | n/a | n/a |
22 | SPI1 | chr17:20458740-20458906 | GM12878 | blood: | n/a | chr17:20458823-20458832 |
23 | SPI1 | chr17:20456356-20456495 | K562 | blood: | n/a | n/a |
24 | SPI1 | chr17:20458592-20459059 | GM12891 | blood: | n/a | chr17:20458823-20458832 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:20450466-20450516 | HRCEpiC | kidney: | n/a |
2 | chr17:20450466-20450516 | HRCEpiC | kidney: | n/a |
3 | chr17:20448558-20448608 | Caco-2 | colon: | n/a |
4 | chr17:20450484-20450534 | MCF10A-Er-Src | breast: | n/a |
5 | chr17:20456385-20456435 | HL-60 | blood: | n/a |
6 | chr17:20456385-20456435 | T-47D | breast: | n/a |
7 | chr17:20448558-20448608 | HPAEpiC | pulmonary alveolar: | n/a |
8 | chr17:20456385-20456435 | LNCaP | prostate: | n/a |
9 | chr17:20456901-20456951 | HIPEpiC | eye: | n/a |
10 | chr17:20456901-20456951 | AG09319 | gingival: | n/a |
11 | chr17:20446526-20446576 | HL-60 | blood: | n/a |
12 | chr17:20458986-20459036 | HL-60 | blood: | n/a |
13 | chr17:20450484-20450534 | NH-A | brain: | n/a |
14 | chr17:20446526-20446576 | BE2_C | brain: | n/a |
15 | chr17:20456901-20456951 | HEK293 | kidney: | embryo |
16 | chr17:20458986-20459036 | PANC-1 | pancreas: | n/a |
17 | chr17:20456385-20456435 | AG04449 | skin: | fetal |
18 | chr17:20458672-20458722 | BE2_C | brain: | n/a |
19 | chr17:20450466-20450516 | AG09319 | gingival: | n/a |
20 | chr17:20450466-20450516 | GM19239 | blood: | n/a |
21 | chr17:20446526-20446576 | Caco-2 | colon: | n/a |
22 | chr17:20450484-20450534 | AG09309 | skin: | n/a |
23 | chr17:20456385-20456435 | BE2_C | brain: | n/a |
24 | chr17:20456901-20456951 | SK-N-MC | brain: | n/a |
25 | chr17:20450484-20450534 | ovcar-3 | ovarian: | n/a |
26 | chr17:20456385-20456435 | SK-N-SH_RA | brain: | n/a |
27 | chr17:20450466-20450516 | PFSK-1 | brain: | n/a |
28 | chr17:20450466-20450516 | NT2-D1 | testis: | n/a |
29 | chr17:20456901-20456951 | NT2-D1 | testis: | n/a |
30 | chr17:20450484-20450534 | PFSK-1 | brain: | n/a |
31 | chr17:20448558-20448608 | ovcar-3 | ovarian: | n/a |
32 | chr17:20458986-20459036 | BE2_C | brain: | n/a |
33 | chr17:20458986-20459036 | HCF | heart: | n/a |
34 | chr17:20456901-20456951 | AG09309 | skin: | n/a |
35 | chr17:20454132-20454182 | AoSMC | blood vessel: | n/a |
36 | chr17:20454132-20454182 | ovcar-3 | ovarian: | n/a |
37 | chr17:20458672-20458722 | AoSMC | blood vessel: | n/a |
38 | chr17:20456901-20456951 | SKMC | muscle: | n/a |
39 | chr17:20456901-20456951 | MCF10A-Er-Src | breast: | n/a |
40 | chr17:20458986-20459036 | T-47D | breast: | n/a |
41 | chr17:20450466-20450516 | BJ | skin: | n/a |
42 | chr17:20456901-20456951 | GM12892 | blood: | n/a |
43 | chr17:20458672-20458722 | PANC-1 | pancreas: | n/a |
44 | chr17:20448558-20448608 | BE2_C | brain: | n/a |
45 | chr17:20458986-20459036 | K562 | blood: | n/a |
46 | chr17:20456901-20456951 | AG04450 | lung: | fetal |
47 | chr17:20456901-20456951 | HPAEpiC | pulmonary alveolar: | n/a |
48 | chr17:20448558-20448608 | H1-hESC | embryonic stem cell: | embryo |
49 | chr17:20456385-20456435 | HRPEpiC | eye: | n/a |
50 | chr17:20458672-20458722 | NHDF-neo | bronchial: | n/a |
No data |
(count:5 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-LGALS9B-12 | chr17:20446287-20446510 | NONHSAT146601 |
2 | lnc-LGALS9B-13 | chr17:20458740-20458896 | NONHSAT146793 |
3 | lnc-LGALS9B-12 | chr17:20447359-20447436 | NONHSAT146601 |
4 | lnc-LGALS9B-13 | chr17:20459470-20459532 | NONHSAT146793 |
5 | lnc-LGALS9B-12 | chr17:20446789-20446842 | NONHSAT146601 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000263946 | TF binding region |
ENSG00000230339 | TF binding region |
TBC1D3P3 | TF binding region |
ENSG00000264981 | TF binding region |
ENSG00000267075 | TF binding region |
ENSG00000263946 | CpG island |
ENSG00000230339 | CpG island |
TBC1D3P3 | CpG island |
ENSG00000264981 | CpG island |
ENSG00000267075 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs550869565 | chr17:20446460-20446461 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs573106204 | chr17:20446461-20446462 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs186445030 | chr17:20446463-20446464 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs682793 | chr17:20446483-20446484 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs536668699 | chr17:20446507-20446508 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs555368974 | chr17:20446535-20446536 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs139008309 | chr17:20446564-20446565 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs540720899 | chr17:20446835-20446836 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs548693074 | chr17:20447007-20447008 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs567302839 | chr17:20447033-20447034 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs534374906 | chr17:20447034-20447035 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs201276527 | chr17:20447057-20447058 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs546728061 | chr17:20447064-20447065 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs571434561 | chr17:20447065-20447066 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs1719918 | chr17:20447135-20447136 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs186038900 | chr17:20447177-20447178 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs56397064 | chr17:20447188-20447189 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs370550362 | chr17:20447391-20447392 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs529161796 | chr17:20447412-20447413 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs553160259 | chr17:20447417-20447418 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs200485479 | chr17:20448402-20448403 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs558523677 | chr17:20448403-20448404 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs570516527 | chr17:20448427-20448428 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs537909753 | chr17:20448435-20448436 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs556633889 | chr17:20448444-20448445 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs199712521 | chr17:20448453-20448454 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs542390181 | chr17:20448481-20448482 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs554107712 | chr17:20448490-20448491 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs146895113 | chr17:20448519-20448520 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs546519805 | chr17:20448524-20448525 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs191297274 | chr17:20448558-20448559 | Inactive region | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs532157484 | chr17:20448559-20448560 | Inactive region | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs543941544 | chr17:20448569-20448570 | Inactive region | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs117230907 | chr17:20448579-20448580 | Inactive region | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs562580539 | chr17:20448601-20448602 | Inactive region | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs529785379 | chr17:20448617-20448618 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs535617509 | chr17:20449292-20449293 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs554342208 | chr17:20449296-20449297 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs572684822 | chr17:20449316-20449317 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs112359036 | chr17:20449380-20449381 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs546483007 | chr17:20449383-20449384 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs558506630 | chr17:20449416-20449417 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs202245700 | chr17:20449460-20449461 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs200481819 | chr17:20450194-20450195 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs529792385 | chr17:20450234-20450235 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs112092589 | chr17:20450467-20450468 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs150708087 | chr17:20450484-20450485 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs527498689 | chr17:20450492-20450493 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs688722 | chr17:20450493-20450494 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs552026970 | chr17:20450519-20450520 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Breast cancer | 17603634 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Smith-Magenis syndrome | 18923513 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 22492990 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 18414209 | CNVD |
Developmental delay | 21549014 | CNVD |
Epilepsy | 20970697 | CNVD |
Mental retardation | 18414209 | CNVD |
Mental retardation | 21549014 | CNVD |
Smith-Magenis syndrome | 21981782 | CNVD |
Smith-Magenis syndrome | 20188345 | CNVD |
Smith-Magenis syndrome | 16775514 | CNVD |
Smith-Magenis syndrome | 22585170 | CNVD |
Smith-Magenis syndrome | 22241247 | CNVD |
Autism | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Potocki-Lupski syndrome | 21271655 | CNVD |
Potocki-lupski syndrome | 17357070 | CNVD |
Potocki-lupski syndrome | 20110824 | CNVD |
Potocki-lupski syndrome | 18923514 | CNVD |
Potocki-lupski syndrome | 22241247 | CNVD |
Potocki-lupski syndrome | 20188345 | CNVD |
Schizophrenia | 21399695 | CNVD |
Mental retardation | 16773131 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Charcot-marie-tooth disease | 22470819 | CNVD |
Neurofibromatosis | 22470819 | CNVD |
Neuropathy | 22470819 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Smith-Magenis syndrome | 17357070 | CNVD |
Smith-Magenis syndrome | 18469339 | CNVD |
Smith-Magenis syndrome | 22241097 | CNVD |
Smith-Magenis syndrome | 22470819 | CNVD |
Tourette syndrome | 18923514 | CNVD |
Type 1 diabetes | 22470819 | CNVD |
Potocki-lupski syndrome | 18469339 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Neuropathy | 17597781 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Smith-Magenis syndrome | 17597781 | CNVD |
Potocki-lupski syndrome | 18059269 | CNVD |
Potocki-lupski syndrome | 17597781 | CNVD |
Mental retardation | 17847001 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21509527 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:20457400-20457600 | Enhancers | Fetal Muscle Trunk | muscle |
2 | chr17:20458600-20459000 | Enhancers | Primary T cells fromperipheralblood | blood |
3 | chr17:20458600-20459200 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
4 | chr17:20458600-20459400 | Enhancers | Primary B cells from peripheral blood | blood |
5 | chr17:20458600-20459400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
6 | chr17:20458600-20459600 | Enhancers | Primary monocytes fromperipheralblood | blood |
7 | chr17:20459000-20459200 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
8 | chr17:20459000-20459400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
9 | chr17:20459000-20459400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |